Traws Pharma, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Traws Pharma, Inc. (TRAW) had Common Stock, Capital Shares Reserved for Future Issuance of 19.88 thousand shares as of 2024-04-01, per its 10-Q filed 2024-11-14.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2024-11-14
- 2024-04-01: Common Stock, Capital Shares Reserved for Future Issuance 19.88K shares; Common Stock, Capital Shares Reserved for Future Issuance as first filed 496.94K shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2024-04-01 | 19.88K shares 10-Q · filed 2024-11-14 | 496.94K shares 10-Q · filed 2024-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |